Diane Ordway

Faculty Microbiology, Immunology, and Pathology

B408 Micro

970-491-7840

About Diane

Immunology, Vaccines and Drugs against Pathogenic Mycobacteria. Worldwide the rate of drug-sensitive, multi-drug and extensively drug resistant Mycobacterium tuberculosis cases are increasing. The only available vaccine against M. tuberculosis, M. bovis Bacillus Calmette-Guérin (BCG) is unreliable and the use of anti-mycobacterial drugs has only lead to high rates of drug resistance. Primarily I am interested in elucidating the T cell and macrophage/dendritic cellular immune responses against Mycobacterium tuberculosis through the use of novel multi-parameter flow cytometry in murine and guinea pigs models. These animal models are used to test vaccines and drugs and provide us with information on the nature of induction of protective immunity. I also collaborate with scientists in clinical research focused on elucidation of the immune mechanisms against Mycobacterium abscessus, Mycobacterium avium and Mycobacterium paratuberculosis.

Education

PhD, University of London, 2000BSc, Colorado State University, 1992

                

stdClass Object ( [GetMemberByIdResult] => stdClass Object ( [AddressPrivacy] => 1 [BusinessAddress1] => [BusinessAddress2] => [BusinessCity] => [BusinessPostalCode] => [BusinessState] => [CSUId] => 0 [DepartmentGroup] => CVMBS Microbiology, Immunology & Pathology Dept [DirectoryPrivacy] => [EName] => dordway [EmailAddress] => D.Ordway@colostate.edu [EmailPrivacy] => [EmployeeCategory] => Faculty [EmployeeTitle] => Faculty [EmployeeType] => Faculty [FirstName] => Diane [GraduationYear] => [HasMemberCV] => [Id] => 3347 [InternalTitle] => Faculty [LastName] => Ordway [MemberContacts] => stdClass Object ( [MemberContactResponse] => stdClass Object ( [ContactTypeDescription] => Office [Id] => 2473 [IsPrimary] => [PhoneNumber] => 970-491-7840 ) ) [MemberDirectoryProfile] => stdClass Object ( [Id] => 81 [ProfileMetaData] => [ProfileText] => Immunology, Vaccines and Drugs against Pathogenic Mycobacteria. Worldwide the rate of drug-sensitive, multi-drug and extensively drug resistant Mycobacterium tuberculosis cases are increasing. The only available vaccine against M. tuberculosis, M. bovis Bacillus Calmette-Guérin (BCG) is unreliable and the use of anti-mycobacterial drugs has only lead to high rates of drug resistance. Primarily I am interested in elucidating the T cell and macrophage/dendritic cellular immune responses against Mycobacterium tuberculosis through the use of novel multi-parameter flow cytometry in murine and guinea pigs models. These animal models are used to test vaccines and drugs and provide us with information on the nature of induction of protective immunity. I also collaborate with scientists in clinical research focused on elucidation of the immune mechanisms against Mycobacterium abscessus, Mycobacterium avium and Mycobacterium paratuberculosis. ) [MiddleName] => [NamePrivacy] => [OfficeBldgName] => Micro [OfficeRoomName] => B408 [OtherName] => Diane [PhonePrivacy] => 1 [StudentLevel] => [Website] => ) )